We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
RAPT Therapeutics Inc | NASDAQ:RAPT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.175 | 2.15% | 8.30 | 8.24 | 8.74 | 8.58 | 8.15 | 8.28 | 587,552 | 01:00:00 |
1. Name and Address of Reporting Person * COLUMN GROUP II, LP | 2. Issuer Name and Ticker or Trading Symbol RAPT Therapeutics, Inc. [ RAPT ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 9/27/2021 | M | 7500 | A | $28.27 | 7500 | I | See Footnote (1) | ||
Common Stock | 9/27/2021 | S | 7500 | D | $34.4808 | 0 | I | See Footnote (1) | ||
Common Stock | 9/27/2021 | M | 1114 | A | $22.20 | 1114 | I | See Footnote (1) | ||
Common Stock | 9/27/2021 | S | 1114 | D | $34.965 | 0 | I | See Footnote (1) | ||
Common Stock | 9/27/2021 | M | 625 | A | $19.30 | 625 | I | See Footnote (1) | ||
Common Stock | 9/27/2021 | S | 625 | D | $34.9446 | 0 | I | See Footnote (1) | ||
Common Stock | 1402008 | D (2) | ||||||||
Common Stock | 163 | I | See Footnote (3) | |||||||
Common Stock | 1599417 | I | See Footnote (4) | |||||||
Common Stock | 145401 | I | See Footnote (5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (Right to Buy) | $28.27 | 9/27/2021 | M | 7500 | (6) | 6/17/2030 | Common Stock | 7500 | $0.00 | 15000 | I | See Footnote (1)(7) | |||
Stock Option (Right to Buy) | $22.20 | 9/27/2021 | M | 1114 | (8) | 3/30/2031 | Common Stock | 1114 | $0.00 | 1115 | I | See Footnote (1)(7) | |||
Stock Option (Right to Buy) | $19.30 | 9/27/2021 | M | 625 | (9) | 5/27/2031 | Common Stock | 625 | $0.00 | 6875 | I | See Footnote (1)(7) |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
COLUMN GROUP II, LP 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO, CA 94129 | X | ||||
Column Group II GP, LP 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO, CA 94129 | X | ||||
PONOI CAPITAL, LP 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO, CA 94129 | X | ||||
Ponoi Management, LLC 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO, CA 94129 | X | ||||
Ponoi Capital II, LP 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO, CA 94129 | X | ||||
Ponoi II Management, LLC 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO, CA 94129 | X | ||||
Kutzkey Tim 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO, CA 94129 | X | ||||
GOEDDEL DAVID V 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO, CA 94129 | X | ||||
Svennilson Peter 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO, CA 94129 | X | ||||
Column Group LLC 1 LETTERMAN DRIVE BUILDING D, SUITE DM-900 SAN FRANCISCO, CA 94129 | X |
Signatures | ||
/s/ James Evangelista, as Attorney-in-fact for David Goeddel | 9/29/2021 | |
**Signature of Reporting Person | Date | |
/s/ James Evangelista, as Attorney-in-fact for Peter Svennilson | 9/29/2021 | |
**Signature of Reporting Person | Date | |
/s/ James Evangelista, as Attorney-in-fact for Tim Kutzkey | 9/29/2021 | |
**Signature of Reporting Person | Date | |
/s/ James Evangelista, as Attorney-in-fact for Ponoi Capital II LP | 9/29/2021 | |
**Signature of Reporting Person | Date | |
/s/ James Evangelista, as Attorney-in-fact for Ponoi II Management LLC | 9/29/2021 | |
**Signature of Reporting Person | Date | |
/s/ James Evangelista, as Attorney-in-fact for Ponoi Capital LP | 9/29/2021 | |
**Signature of Reporting Person | Date | |
/s/ James Evangelista, as Attorney-in-fact for Ponoi Management LLC | 9/29/2021 | |
**Signature of Reporting Person | Date | |
/s/ James Evangelista, as Attorney-in-fact for The Column Group II LP | 9/29/2021 | |
**Signature of Reporting Person | Date | |
/s/ James Evangelista, as Attorney-in-fact for The Column Group II GP LP | 9/29/2021 | |
**Signature of Reporting Person | Date | |
/s/ James Evangelista, as Attorney-in-fact for The Column Group LLC | 9/29/2021 | |
**Signature of Reporting Person | Date |
1 Year RAPT Therapeutics Chart |
1 Month RAPT Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions